Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Aug. 31, 2023
Aug. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss for the period $ (7,363) $ (7,752)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 4,689 4,061
Depreciation and amortization 921 638
Provision for inventory 648 0
Operating lease costs 505 360
Loss from joint venture 625 0
Impairment loss 176 0
Changes in assets and liabilities:    
Accounts receivable 1,968 (1,003)
Deferred revenue (8) 167
Inventory (2,317) (8,917)
Prepaid expenses and other current assets 182 (85)
Other assets (97) 142
Accounts payable and accrued liabilities (3,027) (151)
Operating lease liabilities (530) (244)
NET CASH USED IN OPERATING ACTIVITIES (3,628) (12,784)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchases of property and equipment (342) (2,232)
Equity method investment in joint venture (520) 0
Purchase of patent rights 0 (44)
Cash paid for asset acquisition, net of cash acquired 0 (1,933)
Loan to joint venture (1,556) 0
NET CASH USED IN INVESTING ACTIVITIES (2,418) (4,209)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from stock option exercises 0 457
Repurchase of common stock 0 (15,000)
Payment of taxes withheld on issuance of restricted stock units (456) 0
NET CASH USED IN FINANCING ACTIVITIES (456) (14,543)
Effects of foreign currency exchange rate changes 88 (407)
NET DECREASE IN CASH AND CASH EQUIVALENTS FOR THE PERIOD (6,414) (31,943)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 20,068 56,400
CASH AND CASH EQUIVALENTS END OF PERIOD $ 13,654 $ 24,457